Boston Scientific Option Alert: Nov 7 $102 Calls at the Bid: 7122 vs 7387 OI

Boston Scientific Option Alert: Nov 7 $102 Calls at the Bid: 7122 @ $3.5 vs 7387 OI; Ref=$103.8941

Boston Scientific

BOSTON SCIENTIFIC CORP

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Jim Cramer Reacts To Friday Market Plunge And Hints At His Next Buy

Mid Cap

Media

ANET

GRAL

RBRK

SHAK

TMDX

L&#39;esperto di Mad Money si esprime: quali titoli meritano attenzione e quali no? Analisi e consigli per gli investitori.

Jim Cramer: ecco le azioni che consiglia di comprare (e da evitare)

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

BBIO

ISRG

ITCI

Anticipazioni di mercato rivelano titoli sanitari in crisi: azioni ad alto rischio da valutare per una potenziale vendita immediata.

Questi 4 titoli del settore sanitario potrebbero scoppiare: vendere subito?

Boston Scientific Corporation Common Stock

Boston Scientific Corp

Basilisk - United States dollar

BELO SUN MINING CORP ORD by Belo Sun Mining Corp.

Belo Sun Mining Corp

Press Releases

Archimedes Vascular Announces Close of Series A Financing led by Sherpa Healthcare Partners and Appoints Raymond W. Cohen as Chairman of its Board of Directors

Boston Scientific announces conference call discussing second quarter 2025 results

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

Earnings

Boston Scientific announces results for second quarter 2025

CMCT Announces 30,821-Square-Foot Lease to Boston Scientific Corporation at Penn Field, a 228,000-Square-Foot Creative Office Campus in Austin

Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results

Health Care

Contracts

Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million

Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million

Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.

Boston Scientific announces results for third quarter 2025

CMCT

ELUT

KMTS

Abbott Laboratories

Baxter Intl

Becton, Dickinson and Company Common Stock

Becton Dickinson

DexCom

Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences

GE HealthCare Technologies Inc. - Common Stock

GE HealthCare Techs

Glaukos

Globus Medical, Inc. Class A Common Stock

Globus Medical

Hologic

IDEXX Laboratories

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies

Intuitive Surgical

Masimo

Medtronic

Envista Holdings Corporation Common Stock

Envista Holdings

Penumbra

Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips

Insulet

ResMed

Smith & Nephew

Steris

Stryker

Teleflex

TransMedics Group

Zimmer Biomet Holdings, Inc. Common Stock

Zimmer Biomet Holdings

Truist Securities

Wells Fargo

Morgan Stanley

Canaccord Genuity

Comments

Boston Scientific

Unusual Options Activity for

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO